| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2023 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.15B | 71.55B | 72.57B | 83.66B | 88.13B | 99.69B |
| Gross Profit | 14.92B | 17.24B | 17.96B | 20.58B | 21.47B | 25.09B |
| EBITDA | 3.64B | 4.51B | 2.39B | 4.80B | 3.51B | 7.14B |
| Net Income | 77.00M | 405.00M | -1.60B | 109.00M | -826.00M | 2.86B |
Balance Sheet | ||||||
| Total Assets | 53.63B | 55.97B | 60.72B | 64.12B | 65.75B | 69.23B |
| Cash, Cash Equivalents and Short-Term Investments | 20.18B | 13.22B | 16.42B | 19.18B | 18.66B | 20.12B |
| Total Debt | 7.20B | 7.32B | 8.38B | 7.71B | 7.38B | 8.05B |
| Total Liabilities | 38.69B | 35.55B | 38.92B | 39.92B | 40.68B | 41.37B |
| Stockholders Equity | 18.25B | 20.09B | 21.40B | 23.52B | 23.96B | 26.22B |
Cash Flow | ||||||
| Free Cash Flow | 854.43M | 3.54B | 907.00M | 4.28B | 3.56B | 9.62B |
| Operating Cash Flow | 1.12B | 3.55B | 926.00M | 4.30B | 3.58B | 9.62B |
| Investing Cash Flow | 1.86B | -4.91B | -52.00M | -1.20B | 3.30B | -11.07B |
| Financing Cash Flow | -2.22B | -3.75B | -1.36B | -1.99B | -3.68B | -2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$539.57M | 7.56 | 1.06% | ― | -12.99% | 89.87% | |
55 Neutral | HK$15.07B | -33.42 | 0.40% | 23.73% | -6.17% | ― | |
46 Neutral | HK$88.40M | -0.24 | 60.23% | ― | -3.03% | -36.45% | |
44 Neutral | HK$37.35M | -0.64 | ― | ― | -13.59% | 76.48% | |
42 Neutral | HK$45.99M | -0.10 | -176.89% | ― | -17.63% | -13.10% | |
41 Neutral | HK$414.29M | 2.59 | -404.43% | ― | -12.42% | 62.88% |